Related Experiment Video
Updated: Dec 31, 2025
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets
Xi Chen1, Shuchi Gupta2,3, Matthew Cooper1
1Cardeza Foundation for Hematologic Research, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.
Abstract:
G protein-coupled receptors (GPCRs) mediate the majority of platelet activation in response to agonists. However, questions remain regarding the mechanisms that provide negative feedback toward activated GPCRs to limit platelet activation and thrombus formation. Here we provide the first evidence that GPCR kinase 6 (GRK6) serves this role in platelets, using GRK6-/- mice generated by CRISPR-Cas9 genome editing to examine the consequences of GRK6 knockout on GPCR-dependent signaling. Hemostatic thrombi formed in GRK6-/- mice are larger than in wild-type (WT) controls during the early stages of thrombus formation, with a rapid increase in platelet accumulation at the site of injury. GRK6-/- platelets have increased platelet activation, but in an agonist-selective manner. Responses to PAR4 agonist or adenosine 5'-diphosphate stimulation in GRK6-/- platelets are increased compared with WT littermates, whereas the response to thromboxane A2 (TxA2) is normal. Underlying these changes in GRK6-/- platelets is an increase in Ca2+ mobilization, Akt activation, and granule secretion. Furthermore, deletion of GRK6 in human MEG-01 cells causes an increase in Ca2+ response and PAR1 surface expression in response to thrombin. Finally, we show that human platelet activation in response to thrombin causes an increase in binding of GRK6 to PAR1, as well as an increase in the phosphorylation of PAR1. Deletion of GRK6 in MEG-01 cells causes a decrease in PAR1 phosphorylation. Taken together, these data show that GRK6 regulates the hemostatic response to injury through PAR- and P2Y12-mediated effects, helping to limit the rate of platelet activation during thrombus growth and prevent inappropriate platelet activation.
Insights
GPCR kinase 6 (GRK6) limits platelet activation by negatively regulating G protein-coupled receptors (GPCRs). GRK6 knockout in mice leads to larger thrombi and enhanced platelet responses to specific agonists, revealing its critical role in hemostasis.
Area of Science:
- * Molecular and Cellular Biology
- * Hematology
- * Pharmacology
Background:
- * G protein-coupled receptors (GPCRs) are key mediators of platelet activation.
- * Mechanisms for negative feedback on activated GPCRs in platelets are not fully understood.
- * Understanding these feedback loops is crucial for controlling platelet activation and thrombus formation.
Purpose of the Study:
- * To investigate the role of GPCR kinase 6 (GRK6) in regulating platelet activation and thrombus formation.
- * To determine the impact of GRK6 deficiency on GPCR-dependent signaling pathways in platelets.
- * To elucidate the specific mechanisms by which GRK6 influences hemostasis.
Main Methods:
- * Generation of GRK6 knockout (GRK6-/-) mice using CRISPR-Cas9 genome editing.
- * Analysis of hemostatic thrombus formation in GRK6-/- and wild-type (WT) mice.
- * Assessment of platelet activation, calcium mobilization, Akt activation, and granule secretion in response to various agonists.
- * Studies in human MEG-01 cells to examine GRK6 deletion effects on thrombin-induced responses and PAR1 signaling.
Main Results:
- * GRK6-/- mice exhibited larger hemostatic thrombi with increased early platelet accumulation compared to WT controls.
- * GRK6-/- platelets showed enhanced activation in response to PAR4 agonists and adenosine 5'-diphosphate, but not thromboxane A2.
- * Increased calcium mobilization, Akt activation, and granule secretion were observed in GRK6-/- platelets.
- * Deletion of GRK6 in human cells increased calcium response and PAR1 surface expression upon thrombin stimulation.
- * GRK6 was found to bind to and phosphorylate PAR1 on activated human platelets.
Conclusions:
- * GRK6 plays a significant role in limiting platelet activation and thrombus growth by negatively regulating GPCR signaling.
- * GRK6 deficiency leads to exaggerated platelet responses, particularly to PAR4 and P2Y12 agonists.
- * GRK6 acts through PAR1 and P2Y12 pathways to control hemostasis and prevent inappropriate platelet activation.
Related Concept Videos
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:16Clot Retraction and Fibrinolysis
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...